Delta 9 Cannabis Inc
TSX:DN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Delta 9 Cannabis Inc
TSX:DN
|
CA |
|
H
|
Hav Group ASA
OSE:HAV
|
NO |
|
L
|
Lottomatica Group SpA
MIL:LTMC
|
IT |
|
A
|
Atreca Inc
F:0C1
|
US |
|
D
|
DevPort AB
STO:DEVP B
|
SE |
|
L
|
LSL Pharma Group Inc
XTSX:LSL
|
CA |
|
W
|
Wooree Bio Co Ltd
KOSDAQ:082850
|
KR |
|
Kalbe Farma Tbk PT
IDX:KLBF
|
ID |
|
S
|
Sesen Bio Inc
F:PCBK
|
US |
|
C
|
Cavendish Hydrogen ASA
OSE:CAVEN
|
NO |
|
G
|
Genufood Energy Enzymes Corp
OTC:GFOO
|
US |
|
Schibsted ASA
F:XPG
|
NO |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DN's stock price target?
Not Available
DN doesn't have any price targets made by Wall Street professionals.
What is Delta 9 Cannabis Inc's Revenue forecast?
Projected CAGR
8%
For the last 5 years the
compound annual growth rate for
Delta 9 Cannabis Inc's revenue is
56%.
The projected
CAGR
for the next 1 year is
8%.